πŸ‡ΊπŸ‡Έ FDA
Patent

US 11208405

Pyrrole derivatives as PLK1 inhibitors

granted A61PA61P35/00

Quick answer

US patent 11208405 (Pyrrole derivatives as PLK1 inhibitors) held by SENTINEL ONCOLOGY LIMITED expires Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SENTINEL ONCOLOGY LIMITED
Grant date
Tue Dec 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61P, A61P35/00